Health Shakeup: U.S. Vaccine Policy Blocked Amid Obesity Drug Races
Published on: March 17, 2026, 2:27 a.m. | Source: Devdiscourse
A judge halted Health Secretary Kennedy's attempt to alter vaccine policies due to legal challenges. Structure Therapeutics and Roche's Genentech compete in obesity drug innovation, as BioMarin halts trials over safety issues. Meanwhile, Middle East conflicts threaten pharmaceutical supply chains, escalating concerns over global medicine access.
